By SERB
One year into her role, SERB Pharmaceuticals CEO Vanessa Wolfeler reflects on the strategic acquisition of RSDL® and the company’s growing leadership in global Medical Countermeasures and CBRN preparedness.
In May 2024, SERB Pharmaceuticals marked an exciting leadership milestone with the appointment of Vanessa...
By NCT Consultants
Surrounded by the green hills of the South English countryside, in the picturesque village of Moreton-in-Marsh, NCT Consultants, in partnership with the UK Ministry of Defence, the National CBRN Centre, Cranfield University, and the...
